Synthesis of Methyl (R)-2-O-Propargylglycerate
FULL PAPER
Dry pyridine (2 mL) was added and the solvent was removed under
Methyl
2-O-Propargyl-3-O-{[(R)-3,3,3-trifluoro-2-methoxy-2-
reduced pressure. FC (CH2Cl2/acetone, 50:1) provided 4b (10 mg, phenyl]propionyl}glycerate Hexacarbonyldicobalt Complex (7c, Mix-
84%) as a colourless oil. Rf ϭ 0.25 (CH2Cl2/acetone, 9:1). [α]2D5
ϭ
ture of Stereoisomers): Complex 7b was converted into 7c as de-
ϩ176.5 (c ϭ 0.1, CHCl3). IR (film): ν˜ ϭ 3380 (OH), 1743 cmϪ1 scribed for 4b. FC (CH2Cl2/acetone, 10:1) furnished 7c (not com-
(CO). 1H NMR (200 MHz, HH COSY, CDCl3): δ ϭ 4.43 (dd, pletely pure, 20 mg, 84%) as a red oil. 1H NMR (200 MHz, C6D6):
J1,3 ϭ 2.6, J1,1Ј ϭ 16.1 Hz, 1 H, 1-HI), 4.25 (dd, J1,3 ϭ 2.5, J1Ј,1
16.1 Hz, 1 H, 1-HЈI), 4.29 (m, 1 H, 2-HH), 3.92 (dd, J3,2 ϭ 3.6,
ϭ
δ ϭ 7.78Ϫ7.65 (dd, 2 H, 2-HAr), 7.16Ϫ7.08 (m, 3 H, 3-HAr, 4-HAr),
5.40 (s, 1 H, ϵCH), 4.42, 4.09 (2 ϫ d, 2J1I,1ЈI ϭ 12.3 Hz, 2 H, OCH
J3,3Ј ϭ 11.7 Hz, 1 H, 3-HH), 3.82 (dd, J3Ј,2 ϭ 5.5, J3Ј,3 ϭ 11.7 Hz, 2I), 4.51Ϫ4.43 (dd, J3,3Ј ϭ 11.7, J3,2 ϭ 3.7 Hz, 1 H, 3-HH),
1 H, 3-HЈH), 3.78 (s, 3 H, OCH3), 2.50 (t, J3I,1I ϭ 2.6 Hz, 1 H, 4.38Ϫ4.29 (dd, J3Ј,3 ϭ 11.7, J3Ј,2 ϭ 5.1 Hz, 1 H, 3-HЈH), 3.82Ϫ3.78
CϵCH), 2.30 (s, 1 H, OH) ppm. 13C NMR (50.3 MHz, HETCOR, (dd, J2,3 ϭ 3.7, J2,3Ј ϭ 5.1 Hz, 1 H, 2-HH), 3.47 (br. s, 3 H,
CDCl3): δ ϭ 171.23 (COOCH3), 79.33 (CϵCH), 78.43 (C-2H),
CquatϪOCH3), 3.20, 3.18 (2 ϫ s, ratio 1:1.67, 3 H, COOCH3) ppm.
76.44 (CϵCH), 64.02 (C-3H), 58.60 (OCH2), 52.97 (COOCH3) 1H NMR (200 MHz, CDCl3): δ ϭ 7.65Ϫ7.41 (m, 5 H, Ar H), 5.99
ppm. C7H10O4 (158.15, 158.06), ESI MS: m/z ϭ 159.0 [M ϩ H]ϩ,
278.9 [M ϩ Na]ϩ.
(s, 1 H, ϵCH), 4.87 (d, J1I,1ЈI ϭ 12.3 Hz, 1 H, 1-HI), 4.69Ϫ4.56
2
(m, 3 H, CH2H, 1-HЈI), 4.41 (m, 1 H, 2-HH), 3.68 (br. s, 3 H,
CquatϪOCH3), 3.81, 3.54 (2 ϫ s, ratio 1:1.65, 3 H, COOCH3) ppm.
13C NMR (75 MHz, C6D6): δ ϭ 199.9 (br. s, 6 ϫ CϵO), 168.9
(COOCH3), 164.6 (CquatϪCOO), 132.7, 129.8 (CAr, the other sig-
nals were hidden by the benzene signals), 124.1 (q, 1JC,F ϭ 288 Hz,
CF3), 90.8 (CϵCH), 76.5 (C-2H), 71.3 (ϵCH), 70.9 (OCH2), 65.7
(C-3H), 55.5, 55.1 (OCH3), 51.7 (COOCH3) ppm. 13C NMR
(75 MHz, CDCl3): δ ϭ 199.4 (br. s, 6 ϫ CϵO), 169.6 (COOCH3),
166.4 (CquatϪCOO), 132.1 (C-1Ar), 130.0, 129.8 (C-4Ar), 128.8,
128.6 (C-3Ar), 127.5, 127.4 (C-2Ar), 123.3 (q, 1JF,C ϭ 289 Hz, CF3),
90.0 (CϵCH), 76.5 (C-2H), 71.4 (ϵCH, OCH2), 66.0 (C-3H), 55.8,
55.6 (OCH3), 52.4 (COOCH3) ppm. 19F NMR (282 MHz, C6D6):
two CF3 signals δ ϭ 4.82, 4.53 ppm [ratio 1:1.7] (CF3COOH as
standard).
Methyl 2-O-Propargyl-glycerate Hexacarbonyldicobalt Complex
(7b, Mixture of Enantiomers): The dimethoxyltrityl group was re-
moved from 7a (300 mg, 0.402 mmol) as described for 4a. FC
(CH2Cl2/acetone, 15:1) furnished 7b (107 mg, 60%) as a dark red
oil. Rf ϭ 0.31 (CH2Cl2/acetone, 25:1). IR (film): ν˜ ϭ 1525, 1350,
1093, 1038, 804, 731 cmϪ1. 1H NMR (200 MHz, CDCl3): δ ϭ 6.05
(s, 1 H, ϵCH), 4.98 (d, J1,1Ј ϭ 12.8 Hz, 1 H, 1-HI), 4.64 (d, J1Ј,1 ϭ
12.8 Hz, 1 H, 1-HЈI), 4.28Ϫ4.24 (dd, J2,3 ϭ 3.7, J2,3Ј ϭ 5.1 Hz, 1
H, 2-HH), 4.05Ϫ3.96 (dt, J3,3Ј ϭ 11.7, J3,2 ϭ 3.7, J3,OH ϭ 6.2 Hz,
1 H, 3-HH), 3.93Ϫ3.84 (dt, J3Ј,3 ϭ 11.7, J3Ј,2 ϭ 5.1, J3Ј,OH ϭ 7.3 Hz,
1 H, 3-HЈH), 3.80 (s, 3 H, COOCH3), 2.27 (t, J3,OH ϭ 6.2, J3Ј,OH ϭ
7.3 Hz, 1 H, OH) ppm. 13C NMR (50 MHz, CDCl3): δ ϭ 200.0
(br. s, 6 ϫ CϵO), 172.8 (COOCH3), 91.94 (CϵCH), 81.2 (C-2H),
73.1 (ϵCH), 72.9 (OCH2), 65.7 (C-3H), 54.2 (COOCH3) ppm.
C13H10Co2O10 (444.08, 443.894), FAB MS: m/z (%) ϭ 467 (2) [7b
ϩ Na]ϩ, 416 (6) [7b Ϫ CO]ϩ·, 388 (52) [7b Ϫ 2CO]ϩ·, 360 (65) [7b
Acknowledgments
Financial support by the Deutsche Forschungsgemeinschaft, BC
Biochemie GmbH and the Fonds der Chemischen Industrie is
gratefully acknowledged.
Ϫ 3CO]ϩ·, 332 (100) [7b Ϫ 4CO]ϩ·, 325 (46), 304 (8) [7b Ϫ 5CO]ϩ·
297 (49), 276 (64) [7b Ϫ 6CO]ϩ·, 269 (18), 241 (14).
,
Methyl 2-O-Propargyl-3-O-{[(R)-3,3,3-trifluoro-2-methoxy-2-phenyl]-
propionyl}glycerate (4c)
[1]
N. El-Abadla, M. Lampilas, L. Hennig, M. Findeisen, P. Wel-
zel, D. Müller, A. Markus, J. van Heijenoort, Tetrahedron 1999,
a) Mixture of Stereoisomers Obtained by the Nicholas Route:
DMAP (0.7 mg, 6.3 µmol), triethylamine (18.2 mg, 25 µL,
0.18 mmol) and 3,3,3-trifluoro-2-methoxy-2-phenylpropionyl chlo-
ride (63 mg, 47 µL, 0.24 mmol) were added at 20 °C to a solution
of 4b (20 mg, 0.12 mmol) in dry dichloromethane (2 mL) and the
mixture was stirred at 20 °C overnight. TLC indicated complete
consumption of 4b. Solvent evaporation and FC (toluene/acetone,
25:1) furnished 4c (38.4 mg 83%) as a colourless oil. Rf ϭ 0.56
(toluene/acetone, 10:1). 19F NMR (282 MHz, C6D6): two CF3 sig-
nals, ∆δ ϭ 0.2 ppm [ratio 1:1.6].
55, 699Ϫ722, and references therein.
[2]
A. Anikin, A. Buchynskyy, U. Kempin, K. Stembera, P. Welzel,
G. Lantzsch, Angew. Chem. 1999, 111, 3931Ϫ3935; Angew.
Chem. Int. Ed. 1999, 38, 3703Ϫ3707, see also: A. Buchynskyy,
S. Kempin, L. Hennig, M. Findeisen, D. Müller, S. Giesa, H.
Knoll, P. Welzel, Eur. J. Org. Chem. 2002, 1149Ϫ1162; S. Vogel,
A. Buchynskyy, K. Stembera, K. Richter, L. Hennig, D.
Müller, P. Welzel, Ch. Bonhomme, M. Lampilas, Bioorg. Med.
Chem. Lett. 2000, 20, 1963Ϫ1965.
T. Schubert, F. Kunisch, P. Welzel, Tetrahedron 1983, 39,
2211Ϫ2217.
U. Peters, W. Bankova, P. Welzel, Tetrahedron 1987, 43,
3803Ϫ3816.
U. Eichelberger, I. Neundorf, L. Hennig, M. Findeisen, S.
Giesa, D. Müller, P. Welzel, Tetrahedron 2002, 58, 545Ϫ559.
S. Vogel, K. Stembera, L. Hennig, M. Findeisen, S. Giesa, P.
Welzel, M. Lampilas, Tetrahedron 2001, 57, 4139Ϫ4146.
S. Vogel, K. Stembera, L. Hennig, M. Findeisen, S. Giesa, P.
Welzel, C. Tillier, S. Bonhomme, M. Lampilas, Tetrahedron
2001, 57, 4147Ϫ4160.
U. Eichelberger, M. Mansourova, L. Hennig, M. Findeisen, S.
[3]
[4]
b) Compound 4c Obtained by the Ohira؊Bestmann Route: A mix-
ture of 4b (10 mg, 0.06 mmol), 3,3,3-trifluoro-2-methoxy-2-phenyl-
propionyl chloride (40 µL, 0.30 mmol, 5 equiv.), triethylamine (40
µL) and a catalytic amount of 4-(dimethylamino)pyridine in
CH2Cl2 (0.5 mL) was stirred under argon for 15 h. The solvents
were evaporated. Purification by FC (petroleum ether/ethyl acetate,
[5]
[6]
[7]
1
3:1) furnished 4c (18 mg, 85%). H NMR (200 MHz, CDCl3): δ ϭ
[8]
7.68Ϫ7.63 (m, 2 H, Ar H), 7.07Ϫ6.94 (m, 3 H, Ar H), 4.42 (dd,
Giesa, D. Müller, P. Welzel, Tetrahedron 2001, 57, 9737Ϫ9742.
J
3,2 ϭ 3.3, J3,3Ј ϭ 11.4 Hz, 1 H, 3-HH), 4.08 (dd, J3Ј,2 ϭ 5.1, J3Ј,3 ϭ
[9]
M. Mansourova, Dissertation, University of Leipzig, 2002.
11.4 Hz, 1 H, 3-HЈH), 4.23Ϫ4.15 (dd, J2,3 ϭ 3.3, J2,3Ј ϭ 5.1 Hz, 1
H, 2-HH), 3.96 (t, J1,3 ϭ 2.6 Hz, 2 H, CH2I), 3.42 (q, J ϭ 1.0 Hz, 3
H, OCOCOCH3), 3.07 (s, 3 H, COOCH3), 1.86 (t, J3I,1I ϭ 2.6 Hz,
1 H, CϵCH) ppm. 19F NMR (188.3 MHz, CDCl3): δ ϭ 4.46
(CF3COOH as standard) ppm. 19F NMR (188.3 MHz, C6D6): δ ϭ
4.50 (CF3COOH as standard) ppm.
[10]
K. M. Nicholas, R. F. Lockwood, Tetrahedron Lett. 1977, 48,
4163Ϫ4166.
[11]
K. M. Nicholas, H. D. Hodes, Tetrahedron Lett. 1978, 45,
4349Ϫ4352.
K. M. Nicholas, J. E. O’Boyle, Tetrahedron Lett. 1980, 21,
1595Ϫ1598.
[12]
Eur. J. Org. Chem. 2003, 2656Ϫ2660
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2659